drugset / Trial / NCT04238143

Adipose-Derived Biocellular Regenerative Therapy for Osteoarthritis

NCT04238143 ↗

Non-randomizedParallel-groupOpen-labelTreatment

Summary

Use of Biocellular and cellular approaches to treatment of Osteoarthritis (OA), musculoskeletal aging processes, pain, and degenerative changes are to be studied with minimally invasive protocols, and non-pharmaceutical means to relieve OA and its associated issues. Traditional surgical interventions have not yielded convincing long-term outcomes, including total joint replacement surgeries and medical management of the supportive structures. This study is to use a person's own stem/stromal Cells (autologous) plus HD-PRP (important healing growth factors and signal molecules) in such cases of OA for long-term minimally invasive treatments. Baseline (existing) findings are documented, and thence tracked as to progress deemed to be result of the intervention.

Timeline

Start
2020-01-10
Primary completion
2026-09-30
Completion
2027-09-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject PRP Concentrate Unknown — —